Combination Facial Aesthetic Treatment in Millennials

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 9, 2021

Primary Completion Date

May 19, 2021

Study Completion Date

May 19, 2021

Conditions

Dermatological Non-Disease

Interventions

DRUG

Botox Cosmetic Injectable Product

Acetylcholine release inhibitor and a neuromuscular blocking agent

DEVICE

Juvéderm Voluma XC

Gel implants consisting of cross-linked hyaluronic acid

DEVICE

Juvéderm Volbella XC

Gel implants consisting of cross-linked hyaluronic acid

Trial Locations (1)

SUNY Downstate Health Sciences University, Brooklyn

All Listed Sponsors

collaborator

Allergan Sales, LLC

INDUSTRY

lead

State University of New York - Downstate Medical Center

OTHER

NCT04755595 - Combination Facial Aesthetic Treatment in Millennials | Biotech Hunter | Biotech Hunter